PTHLH coupling upstream negative regulation of fatty acid biosynthesis and Wnt receptor signal to downstream peptidase activity-induced apoptosis network in human hepatocellular carcinoma by systems-theoretical analysis

Journal of Receptors and Signal Transduction

Volumn 32, Issue 5, 2012, Pages 250-256

  Huang, Juxiang ^a   Wang, Lin ^a   Jiang, Minghu ^b   Lin, Hong ^a   Qi, Lianxiu ^a   Diao, Haizhen ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b TSINGHUA UNIVERSITY   (China)

Author keywords

Computation; The corresponding activated and inhibited GO network of no tumor hepatitis cirrhotic tissues; The corresponding inhibited GO network of HCC; The same PTHLH feedback negative regulation mediated apoptosis GO and molecular network of HCC

Indexed keywords

BRCA1 PROTEIN; FRIZZLED PROTEIN; P21 ACTIVATED KINASE; PEPTIDASE; UBIQUITIN;

ANAPHASE; APOPTOSIS; ARTICLE; CENTRIOLE; COMPLEX FORMATION; CONTROLLED STUDY; FATTY ACID SYNTHESIS; GENE REGULATORY NETWORK; HEPATITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; NEGATIVE FEEDBACK; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; THEORETICAL MODEL;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; COMPUTATIONAL BIOLOGY; FATTY ACIDS; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; MODELS, THEORETICAL; PARATHYROID HORMONE-RELATED PROTEIN; PEPTIDE HYDROLASES; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TUMOR SUPPRESSOR PROTEIN P53; WNT SIGNALING PATHWAY;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 84866630489     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.3109/10799893.2012.700717     Document Type: Article

References (38)

1. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, Gupta S, et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 2008, 359, 1995-2004.
2. Gianni-Barrera R, Gariboldi M, De Cecco L, Manenti G, Dragani TA. Specific gene expression profiles distinguish among functional allelic variants of the mouse Pthlh gene in transfected human cancer cells. Oncogene 2006, 25, 4501-4504.
3. Brandt DW, Wachsman W, Deftos LJ. Parathyroid hormone-like protein: alternative messenger RNA splicing pathways in human cancer cell lines. Cancer Res 1994, 54, 850-853.
4. Liapis H, Crouch EC, Roby J, Rader JS. In situ localization of parathyroid hormone-like protein and mRNA in intraepithelial neoplasia and invasive carcinoma of the uterine cervix. Hum Pathol 1993, 24, 1058-1066.
5. Deftos LJ, Burton DW, Brandt DW. Parathyroid hormone-like protein is a secretory product of atrial myocytes. J Clin Invest 1993, 92, 727-735.
6. Connor C, Drees B, Hamilton J. Parathyroid hormone-like peptide and parathyroid hormone are secreted from bovine parathyroid via different pathways. Biochim Biophys Acta 1993, 1178, 81-86.
7. Miraliakbari BA, Asa SL, Boudreau SF. Parathyroid hormone-like peptide in pancreatic endocrine carcinoma and adenocarcinoma associated with hypercalcemia. Hum Pathol 1992, 23, 884-887.
8. Loveridge N, Dean V, Goltzman D, Hendy GN. Bioactivity of parathyroid hormone and parathyroid hormone-like peptide: agonist and antagonist activities of amino-terminal fragments as assessed by the cytochemical bioassay and in situ biochemistry. Endocrinology 1991, 128, 1938-1946.
9. Kramer S, Reynolds FH Jr, Castillo M, Valenzuela DM, Thorikay M, Sorvillo JM. Immunological identification and distribution of parathyroid hormone-like protein polypeptides in normal and malignant tissues. Endocrinology 1991, 128, 1927-1937.
10. Henderson J, Sebag M, Rhim J, Goltzman D, Kremer R. Dysregulation of parathyroid hormone-like peptide expression and secretion in a keratinocyte model of tumor progression. Cancer Res 1991, 51, 6521-6528.
11. Brandt DW, Burton DW, Gazdar AF, Oie HE, Deftos LJ. All major lung cancer cell types produce parathyroid hormonelike protein: heterogeneity assessed by high performance liquid chromatography. Endocrinology 1991, 129, 2466-2470.
12. McAuley P, Asa SL, Chiu B, Henderson J, Goltzman D, Drucker DJ. Parathyroid hormone-like peptide in normal and neoplastic mesothelial cells. Cancer 1990, 66, 1975-1979.
13. Storey JD. A direct approach to false discovery rates. J Roy Stat Soc Ser B 2002, 64, 479-498.
14. Wang Y, Joshi T, Zhang XS, Xu D, Chen L. Inferring gene regulatory networks from multiple microarray datasets. Bioinformatics 2006, 22, 2413-2420.
15. Wang L, Sun Y, Jiang M, Zheng X. Integrative decomposition procedure and Kappa statistics for the distinguished single molecular network construction and analysis. J Biomed Biotechnol 2009, 2009, 726728.
16. Wang L, Sun Y, Jiang M, Zhang S, Wolfl S. FOS proliferating network construction in early colorectal cancer (CRC) based on integrative significant function cluster and inferring analysis. Cancer Invest 2009, 27, 816-824.
17. Wang L, Sun L, Huang J, Jiang M. Cyclin-dependent kinase inhibitor 3 (CDKN3) novel cell cycle computational network between human non-malignancy associated hepatitis/cirrhosis and hepatocellular carcinoma (HCC) transformation. Cell Prolif 2011, 44, 291-299.
18. Wang L, Huang J, Jiang M, Zheng X. AFP computational secreted network construction and analysis between human hepatocellular carcinoma (HCC) and no-tumor hepatitis/cirrhotic liver tissues. Tumour Biol 2011, 31, 417-425.
19. Wang L, Huang J, Jiang M, Sun L. MYBPC1 computational phosphoprotein network construction and analysis between frontal cortex of HIV encephalitis (HIVE) and HIVE-control patients. Cell Mol Neurobiol 2011, 31, 233-241.
20. Wang L, Huang J, Jiang M, Sun L. Survivin (BIRC5) cell cycle computational network in human no-tumor hepatitis/cirrhosis and hepatocellular carcinoma transformation. J Cell Biochem 2011, 112, 1286-1294.
21. Wang L, Huang J, Jiang M, Lin H. Signal transducer and activator of transcription 2 (STAT2) metabolism coupling postmitotic outgrowth to visual and sound perception network in human left cerebrum by biocomputation. J Mol Neurosci 2012, 47, 649-658.
22. Wang L, Huang J, Jiang M. RRM2 computational phosphoprotein network construction and analysis between no-tumor hepatitis/ cirrhotic liver tissues and human hepatocellular carcinoma (HCC). Cell Physiol Biochem 2011, 26, 303-310.
23. Wang L, Huang J, Jiang M. CREB5 computational regulation network construction and analysis between frontal cortex of HIV encephalitis (HIVE) and HIVE-control patients. Cell Biochem Biophys 2011, 60, 199-207.
24. Sun Y, Wang L, Lui L. Integrative decomposition procedure and Kappa statistics set up ATF2 ion binding module in malignant pleural mesothelioma (MPM). Front Electr Electron Eng China 2008, 3, 381-387.
25. Sun Y, Wang L, Jiang M, Huang J, Liu Z, Wolfl S. Secreted phosphoprotein 1 upstream invasive network construction and analysis of lung adenocarcinoma compared with human normal adjacent tissues by integrative biocomputation. Cell Biochem Biophys 2010, 56, 59-71.
26. Sun L, Wang L, Jiang M, Huang J, Lin H. Glycogen debranching enzyme 6 (AGL), enolase 1 (ENOSF1), ectonucleotide pyrophosphatase 2 (ENPP2-1), glutathione S-transferase 3 (GSTM3-3) and mannosidase (MAN2B2) metabolism computational network analysis between chimpanzee and human left cerebrum. Cell Biochem Biophys 2011, 61, 493-505.
27. Huang JX, Wang L, Jiang MH. TNFRSF11B computational development network construction and analysis between frontal cortex of HIV encephalitis (HIVE) and HIVE-control patients. J Inflamm (Lond) 2011, 7, 50.
28. Huang J, Wang L, Jiang M, Zheng X. Interferon α-inducible protein 27 computational network construction and comparison between the frontal cortex of HIV encephalitis (HIVE) and HIVE-control patients. Open Genomics J 2010, 3, 1-8.
29. Doubravska L, Krausova M, Gradl D, Vojtechova M, Tumova L, Lukas J, Valenta T, et al. Fatty acid modification of Wnt1 and Wnt3a at serine is prerequisite for lipidation at cysteine and is essential for Wnt signalling. Cell Signal 2012, 23, 837-848.
30. Takada R, Satomi Y, Kurata T, Ueno N, Norioka S, Kondoh H, Takao T, Takada S. Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion. Dev Cell 2006, 11, 791-801.
31. Terrand J, Bruban V, Zhou L, Gong W, El Asmar Z, May P, Zurhove K, et al. LRP1 controls intracellular cholesterol storage and fatty acid synthesis through modulation of Wnt signaling. J Biol Chem 2009, 284, 381-388.
32. Benchabane H, Ahmed Y. The adenomatous polyposis coli tumor suppressor and Wnt signaling in the regulation of apoptosis. Adv Exp Med Biol 2009, 656, 75-84.
33. Bury M, Mlynarczuk I, Pleban E, Hoser G, Kawiak J, Wójcik C. Effects of an inhibitor of tripeptidyl peptidase II (Ala-Ala- Phechloromethylketone) and its combination with an inhibitor of the chymotrypsin-like activity of the proteasome (PSI) on apoptosis, cell cycle and proteasome activity in U937 cells. Folia Histochem Cytobiol 2001, 39, 131-132.
34. Hirata H, Hinoda Y, Nakajima K, Kawamoto K, Kikuno N, Ueno K, Yamamura S, et al. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma. Int J Cancer 2012, 128, 1793-1803.
35. Ramachandran I, Thavathiru E, Ramalingam S, Natarajan G, Mills WK, Benbrook DM, Zuna R, et al. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo. Oncogene 2012, 31, 2725-2737.
36. Shi Y, He B, Kuchenbecker KM, You L, Xu Z, Mikami I, Yagui- Beltran A, et al. Inhibition of Wnt-2 and galectin-3 synergistically destabilizes beta-catenin and induces apoptosis in human colorectal cancer cells. Int J Cancer 2007, 121, 1175-1181.
37. Ueda Y, Hijikata M, Takagi S, Takada R, Takada S, Chiba T, Shimotohno K. Wnt/beta-catenin signaling suppresses apoptosis in low serum medium and induces morphologic change in rodent fibroblasts. Int J Cancer 2002, 99, 681-688.
38. Yang F, Zeng Q, Yu G, Li S, Wang CY. Wnt/beta-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC. Cell Signal 2006, 18, 679-687.